October 17, 2024 Opportunities and Challenges to Support Pa.’s Aging Population A strong health care system is vital for an aging Pennsylvania.
October 16, 2024 The Return of Whooping Cough Whooping cough has made a return to pre-pandemic levels, with more than five times as many cases reported this year compared to last year, according to the CDC.
October 15, 2024 How Housing Impacts Health Pennsylvania’s hospitals are investing in programs to address housing needs in their communities and support social determinants of health.
October 14, 2024 The Growing Toll of a Cyberattack An overwhelming majority of health care organizations reported at least one cyberattack during the past 12 months, according to new survey.
October 10, 2024 State Legislative Roundup: Lawmakers Advance Several Health Bills With only a few days left in the legislative session, the Pennsylvania General Assembly this week advanced several bills addressing the health care workforce, maternal health, insurance coverage, and changes in state agencies.
October 09, 2024 Baxter Outlines Timeline to Restart Production for IV Fluids Baxter International today announced the timeline to restart production at its North Carolina facility that produces most of the intravenous fluids (IV) in the U.S.
October 08, 2024 A New Cyber Threat to Watch The federal government is warning of another emerging cybersecurity threat that has targeted the health sector.
October 07, 2024 HAP Strongly Opposes State Mergers and Acquisitions Bill In a letter today, HAP and the Pennsylvania hospital community strongly opposed legislation that would create new regulatory burdens for hospitals while threatening access to care.
October 04, 2024 CMS Sets Stage for Next Round of Drug Negotiations CMS has released new guidance outlining the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.
October 02, 2024 J&J Reverses Plan for 340B Drug Rebate Johnson and Johnson (J&J) announced this week it was forgoing a controversial plan to offer rebates for certain 340B drugs instead of direct drug discounts.